Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide

International Journal of Hematology

Volumn 94, Issue 6, 2011, Pages 583-584

  Morita, Yasuyoshi ^a   Shimada, Takahiro ^a   Yamaguchi, Terufumi ^a   Rai, Shinya ^a   Hirase, Chikara ^a   Emoto, Masakatsu ^a   Serizawa, Kentaro ^a   Taniguchi, Yasuhiro ^a,b   Ojima, Mayuko ^a   Tatsumi, Yoichi ^a   Ashida, Takashi ^a   Matsumura, Itaru ^a  

^a KINKI UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LENALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; LETTER; LEUKOCYTE COUNT; MALE; MONOTHERAPY; MOUTH INFECTION; MULTIPLE MYELOMA; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; CYTOKINES; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RECURRENCE; THALIDOMIDE;

EID: 84355161425     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0973-x     Document Type: Letter

References (5)

1. S Ozaki T Harada S Fujii S Nakamura H Miki A Nakano, et al. 2011 Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma Int J Hematol 93 257 259 21279817 10.1007/s12185-011-0775-1
2. PG Richardson RL Schlossman E Weller T Hideshima C Mitsiades F Davies, et al. 2002 Immunomodulatory drug CC5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Blood 100 3063 3067 12384400 10.1182/blood-2002-03-0996 1:CAS:528:DC%2BD38XosVSis78%3D (Pubitemid 35217050)
3. M Zangari F Elice G Tricot 2005 Immunomodulatory drugs in multiple myeloma Expert Opin Investig Drugs 14 1411 1418 16255679 10.1517/13543784.14.11. 1411 1:CAS:528:DC%2BD2MXhtFGqsrnJ (Pubitemid 41601455)
4. H Quach D Ritchie AK Stewart P Neason S Harrison MJ Smyth, et al. 2010 Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma Leukemia. 24 22 32 19907437 10.1038/leu.2009.236 1:CAS:528: DC%2BC3cXltlejsg%3D%3D
5. K Dredge JB Marriott CD Macdonald 2002 Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects Br J Cancer 87 1166 1172 12402158 10.1038/sj.bjc.6600607 1:CAS:528: DC%2BD38XotFWrurk%3D (Pubitemid 35418112)